• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007 年至 2013 年期间澳大利亚和新西兰重症监护病房复苏液的使用情况。

Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.

机构信息

Division of Critical Care and Trauma, The George Institute for Global Health, University of Sydney, Sydney, Australia,

出版信息

Intensive Care Med. 2015 Sep;41(9):1611-9. doi: 10.1007/s00134-015-3878-y. Epub 2015 Jun 3.

DOI:10.1007/s00134-015-3878-y
PMID:26077073
Abstract

INTRODUCTION

Recent evidence indicates that the choice of intravenous fluids may affect outcomes in critically ill patients.

METHODS

We recorded the administration of resuscitation fluids in patients admitted to Australian and New Zealand adult intensive care units (ICUs) for a 24-h period at 6 time points between 2007 and 2013. Changes in patterns of fluid use over this period were determined using regression analyses.

RESULTS

Of the 2825 patients admitted to the 61 ICUs on the 6 study days, 754 (26.7%) patients received fluid resuscitation. Of those receiving fluid resuscitation, the proportion of patients receiving crystalloid significantly increased from 28.9% (41/142) in 2007 to 50.5% (48/95) in 2013 (adjusted odds ratio (OR) 2.93; 95% confidence intervals (CI) 1.35-6.33; p = 0.006); of these, the proportion of patients receiving buffered salt solutions significantly increased from 4.9% (7/142) in 2007 to 31.6% (30/95) in 2013 (OR 7.00; 95% CI 2.14-22.92; p = 0.001). The use of colloids significantly decreased from 59.9% (85/142) in 2007 to 42.1% (40/95) in 2013 (adjusted OR 0.34; 95% CI 0.16-0.74; p = 0.007) due to a significant decrease in the proportion of patients receiving gelatin; 28.9% (41/142) to 2.1% (2/95) (OR 0.10; 95% CI 0.03-0.29; p ≤ 0.001).

CONCLUSION

Fluid resuscitation practice in Australia and New Zealand adult ICUs has changed over the 6-year study period. Crystalloid use increased primarily due to an increase in the use of buffered salt solutions while overall the use of colloid has decreased.

摘要

引言

最近的证据表明,静脉输液的选择可能会影响危重症患者的结局。

方法

我们记录了 2007 年至 2013 年期间的 6 天内,澳大利亚和新西兰成人重症监护病房(ICU)中 61 个 ICU 每 24 小时接受复苏液治疗的患者的输液情况。使用回归分析确定在此期间液体使用模式的变化。

结果

在 6 个研究日入住 61 个 ICU 的 2825 名患者中,754 名(26.7%)患者接受了液体复苏。在接受液体复苏的患者中,接受晶体液的患者比例从 2007 年的 28.9%(41/142)显著增加到 2013 年的 50.5%(48/95)(调整后的优势比(OR)2.93;95%置信区间(CI)1.35-6.33;p=0.006);其中,接受缓冲盐溶液的患者比例从 2007 年的 4.9%(7/142)显著增加到 2013 年的 31.6%(30/95)(OR 7.00;95%CI 2.14-22.92;p=0.001)。胶体的使用从 2007 年的 59.9%(85/142)显著减少到 2013 年的 42.1%(40/95)(调整后的 OR 0.34;95%CI 0.16-0.74;p=0.007),主要是由于接受明胶的患者比例显著减少,从 28.9%(41/142)降至 2.1%(2/95)(OR 0.10;95%CI 0.03-0.29;p≤0.001)。

结论

在 6 年的研究期间,澳大利亚和新西兰成人 ICU 的液体复苏实践发生了变化。晶体液的使用增加主要是由于缓冲盐溶液的使用增加,而胶体的总体使用减少。

相似文献

1
Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.2007 年至 2013 年期间澳大利亚和新西兰重症监护病房复苏液的使用情况。
Intensive Care Med. 2015 Sep;41(9):1611-9. doi: 10.1007/s00134-015-3878-y. Epub 2015 Jun 3.
2
Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study.2007年至2014年间成年重症监护患者静脉输液复苏的使用模式:一项国际横断面研究。
PLoS One. 2017 May 12;12(5):e0176292. doi: 10.1371/journal.pone.0176292. eCollection 2017.
3
Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units.危重症成人复苏液使用情况:391 个重症监护病房的国际横断面研究。
Crit Care. 2010;14(5):R185. doi: 10.1186/cc9293. Epub 2010 Oct 15.
4
Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial.胶体溶液与晶体溶液复苏对低血容量性休克危重症患者死亡率的影响:CRISTAL 随机试验。
JAMA. 2013 Nov 6;310(17):1809-17. doi: 10.1001/jama.2013.280502.
5
Choice of Fluids for Resuscitation of the Critically Ill: What Nurses Need to Know.危重症患者复苏的液体选择:护士需要了解的内容。
Crit Care Nurs Q. 2017 Oct/Dec;40(4):309-322. doi: 10.1097/CNQ.0000000000000170.
6
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.单独使用合成胶体或晶体液复苏对严重脓毒症休克逆转、液体平衡和患者结局的影响:一项前瞻性序贯分析。
Crit Care Med. 2012 Sep;40(9):2543-51. doi: 10.1097/CCM.0b013e318258fee7.
7
Resuscitating patients with early severe sepsis: a Canadian multicentre observational study.对早期重症脓毒症患者进行复苏:一项加拿大多中心观察性研究。
Can J Anaesth. 2007 Oct;54(10):790-8. doi: 10.1007/BF03021706.
8
Maintenance fluid practices in intensive care units in Australia and New Zealand.澳大利亚和新西兰重症监护病房的维持液应用实践
Crit Care Resusc. 2016 Jun;18(2):89-94.
9
Fluid as a Drug: Balancing Resuscitation and Fluid Overload in the Intensive Care Setting.作为药物的液体:重症监护环境中复苏与液体超负荷的平衡
Adv Chronic Kidney Dis. 2016 May;23(3):152-9. doi: 10.1053/j.ackd.2016.02.006.
10
Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock.在成人脓毒性休克复苏期间,初始液体选择与随后院内死亡率之间的关联。
Anesthesiology. 2015 Dec;123(6):1385-93. doi: 10.1097/ALN.0000000000000861.

引用本文的文献

1
Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trial.人血白蛋白溶液液量冲击疗法在心脏手术后患者中的应用-II:一项多中心随机对照试验。
Intensive Care Med. 2024 Jul;50(7):1075-1085. doi: 10.1007/s00134-024-07488-3. Epub 2024 Jul 2.
2
Effect of a single small volume fluid bolus with balanced or un-balanced fluids on chloride and acid-base status: a prospective randomized pilot study (the FLURES-trial).单次小容量平衡液或非平衡液冲击对氯及酸碱状态的影响:一项前瞻性随机试验性研究(FLURES试验)
J Nephrol. 2024 Jun;37(5):1299-1308. doi: 10.1007/s40620-024-01912-z. Epub 2024 Mar 28.
3

本文引用的文献

1
Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis.氯离子自由与限制的静脉输液治疗与急性肾损伤:一项扩展分析。
Intensive Care Med. 2015 Feb;41(2):257-64. doi: 10.1007/s00134-014-3593-0. Epub 2014 Dec 18.
2
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.严重脓毒症患者晶体液选择与院内死亡率的关系*。
Crit Care Med. 2014 Jul;42(7):1585-91. doi: 10.1097/CCM.0000000000000305.
3
Albumin replacement in patients with severe sepsis or septic shock.
Study protocol and statistical analysis plan for the 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients after Cardiac Surgery-ll (HAS FLAIR-II) trial.
心脏手术后患者20%人血白蛋白溶液推注治疗试验(HAS FLAIR-II)的研究方案和统计分析计划
Crit Care Resusc. 2023 Oct 16;24(4):309-318. doi: 10.51893/2022.4.OA1. eCollection 2022 Dec 5.
4
Violence in intensive care: a point prevalence study.重症监护病房中的暴力行为:一项现况调查研究。
Crit Care Resusc. 2023 Oct 18;24(3):272-279. doi: 10.51893/2022.3.OA7. eCollection 2022 Sep 5.
5
Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS.巴西重症监护病房的复苏液体应用:Fluid-TRIPS的二次分析
Rev Bras Ter Intensiva. 2021 Apr-Jun;33(2):206-218. doi: 10.5935/0103-507X.20210028.
6
Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.醋酸林格氏液与 0.9%生理盐水用于脓毒症患者的比较:一项多中心平行对照试验的研究方案。
Trials. 2021 Jan 25;22(1):89. doi: 10.1186/s13063-020-05007-5.
7
Balanced Crystalloid Solutions.平衡晶体溶液。
Am J Respir Crit Care Med. 2019 Apr 15;199(8):952-960. doi: 10.1164/rccm.201809-1677CI.
8
Resuscitation fluids.复苏液。
Curr Opin Crit Care. 2018 Dec;24(6):512-518. doi: 10.1097/MCC.0000000000000551.
9
Personalised fluid resuscitation in the ICU: still a fluid concept?重症监护病房中的个体化液体复苏:仍是一个模糊的概念?
Crit Care. 2017 Dec 28;21(Suppl 3):313. doi: 10.1186/s13054-017-1909-5.
10
An increased chloride level in hypochloremia is associated with decreased mortality in patients with severe sepsis or septic shock.低氯血症患者氯离子水平升高与严重脓毒症或感染性休克患者死亡率降低相关。
Sci Rep. 2017 Nov 21;7(1):15883. doi: 10.1038/s41598-017-16238-z.
严重脓毒症或脓毒性休克患者的白蛋白替代治疗。
N Engl J Med. 2014 Apr 10;370(15):1412-21. doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18.
4
Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*.*生理盐水与平衡电解质溶液复苏对脓毒症大鼠急性肾损伤的影响*。
Crit Care Med. 2014 Apr;42(4):e270-8. doi: 10.1097/CCM.0000000000000145.
5
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.羟乙基淀粉(HES)与其他液体疗法:对肾功能的影响。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3.
6
Colloids versus crystalloids for fluid resuscitation in critically ill patients.胶体液与晶体液用于危重症患者液体复苏的比较
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000567. doi: 10.1002/14651858.CD000567.pub6.
7
Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.羟乙基淀粉给药与需要容量复苏的危重症患者死亡率和急性肾损伤的关系:系统评价和荟萃分析。
JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430.
8
Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.羟乙基淀粉 130/0.38-0.45 与晶体或白蛋白在脓毒症患者中的比较:系统评价与荟萃分析和试验序贯分析。
BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839.
9
Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.急性病患者中用 6%羟乙基淀粉(130/0.4 和 130/0.42)进行液体复苏:对死亡率和肾脏替代治疗影响的系统评价。
Intensive Care Med. 2013 Apr;39(4):558-68. doi: 10.1007/s00134-013-2840-0. Epub 2013 Feb 14.
10
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南,2012 年。
Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30.